TargetMol

Lipopolysaccharides, from S. enterica serotype abortus equi

Product Code:
 
TAR-TSW-00907
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
 

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-TSW-00907-100mg100 mgEnquire
Quantity:
TAR-TSW-00907-250mg250 mgEnquire
Quantity:
TAR-TSW-00907-50mg50 mgEnquire
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Austria.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Bioactivity:
Lipopolysaccharides from *Salmonella enterica* serotype Abortusequi are endotoxins and TLR-4 activators derived from intestinal S. enterica. They are mutated R-type LPSs that serve as pathogen-associated molecular patterns (PAMP) to activate the immune system and induce cell secretion of exosomes. These lipopolysaccharides consist of a core oligosaccharide and lipid A. *S. enterica* serotype Abortusequi is a key pathogen causing abortion in mares and is associated with neonatal septicemia, multiple abscesses, orchitis, and polyarthritis in equine species. Grouping is primarily based on lipopolysaccharide (O-antigen) and flagellin protein (H-antigen).
Pathway:
Immunology/Inflammation
Target:
TLR

Documents